Dihydromagnolol - A potent anxiolytic-like agent in mice

Hisashi Kuribara, Eiko Kishi, Masayuki Kimura, Susan T. Weintraub, Yoshihisa Ito, Yuji Maruyama

Research output: Contribution to journalArticlepeer-review


Oral administration of a single 1 mg/kg dose of dihydromagnolol [DHM; 5′-(2-propenyl)-5-propyl-(1,1′-biphenyl)-2,2′-diol] produced a significant anxiolytic-like effect in mice, as assessed in an elevated plus-maze test. This dose did not cause any marked change in ambulatory activity. The anxiolytic-like effect peaked at 1 h and persisted for more than 3 h after administration. Significant anxiolytic-like activity at a dose of 1 mg/kg of dihydromagnolol was also indicated by use of Vogel's conflict test. Although dihydromagnolol enhanced 36Cl- uptake into mouse cortical synaptoneurosomes in the absence of muscimol in in vitro experiments, it did not alter the activities of diazepam, flumazenil or bicuculline in vivo. The results of these studies suggest that the anxiolytic-like activity of DHM occurs through action at a site(s) in the nervous system other than the GABAA/benzodiazepine receptor complex which is the site of action of the traditional benzodiazepine anxiolytics.

Original languageEnglish (US)
Pages (from-to)31-36
Number of pages6
JournalPharmaceutical Biology
Issue number1
StatePublished - Feb 2003


  • Anxiolytic-like effect
  • Cl uptake
  • Dihydromagnolol
  • Elevated plus-maze test
  • Motor activity
  • Vogel's conflict test

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery
  • Complementary and alternative medicine


Dive into the research topics of 'Dihydromagnolol - A potent anxiolytic-like agent in mice'. Together they form a unique fingerprint.

Cite this